Clinical Trial Update: Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan [Phase 2]

View source ↗

Summary

Phase 2 trial assessing calcium aluminosilicate as an anti-diarrheal to treat and prevent diarrhea in patients with metastatic colorectal cancer receiving irino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Calcium aluminosilicate

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chemotherapeutic Agent Toxicity, Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-12-02